[vc_row top_margin=”none” el_position=”first”] [vc_column top_margin=”none”] [mc_carousel id=”carousel” carousel_images=”2773,2772,2771,2770″ features_images_loop=”1″ lightbox_icon_color=”blue_light” autoplay=”0″ pause_on_hover=”1″ scroll=”1″ effect=”scroll” easing=”swing” duration=”500″ top_margin=”page_margin_top_section” el_position=”first last”] [/vc_column] [/vc_row] [vc_row top_margin=”none” el_position=”last”] [vc_column top_margin=”none”] [vc_column_text el_position=”first last”]
Epigenetics therapy shows promise in patients with lymphoma
March, 2018
https://www.sciencedaily.com/releases/2018/03/180305092848.htm
Combination Drug Trial Launched to Eradicate B-Cell Malignancies
March, 2018
http://www.lymphomahub.com/medical-information/fda-approves-sbla-for-new-four-week-dosing-schedule-of-opdivo-nivolumab
Lymphoma Drug Gets Trio of FDA Approvals
Med Page Today
July 23, 2014
http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/46902
US FDA clears Lorus’ IND application to begin LOR-253 clinical programme in patients with AML, MDS & other blood cancers
Pharmabiz.com
July 29, 2014
http://www.pharmabiz.com/NewsDetails.aspx?aid=83208&sid=2
Spectrum Pharma’s Beleodaq Granted Accelerated Approval by US FDA
StreetInsider.com
July 7, 2014
http://www.streetinsider.com/Corporate+News/Spectrum+Pharmas+(SPPI)+Beleodaq+Granted+Accelerated+Approval+by+U.S.+FDA/9640550.html
Now Enrolling Patients for Lymphoma Clinical Trials at Manhattan Hematology Oncology Associates.
[/vc_column_text] [/vc_column] [/vc_row]